<u id="zkwwc"><dd id="zkwwc"></dd></u>

<sub id="zkwwc"></sub>
<dd id="zkwwc"></dd><nav id="zkwwc"></nav>

        Contact Us

        For IR related enquiries please contact:



        For product related enquiries please see below

        If you would like to order one of our products, please email: orders@abcam.com

        If you have a technical question about one of our products, please email: technical@abcam.com

        If your enquiry is about something else,?please complete the form below.


        Corporate Headquarters

        Abcam plc
        Discovery Drive
        Cambridge Biomedical Campus
        CB2 0AX
        F: +44 (0)1223 215 215

        Additional Contacts

        Nominated Advisors and Corporate Broker

        J.P. Morgan Cazenove
        25 Bank Street
        Canary Wharf
        London E14 5JP

        Public Relations Advisors

        FTI Consulting
        200 Aldersgate
        Aldersgate Street
        London EC1A 4HD
        F: +44 (0)20 3727 1007

        Joint Corporate Broker

        Numis Securities Limited
        The London Stock Exchange Building,
        10 Paternoster Square, London,
        EC4M 7LT

        About Abcam

        Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

        Read more +

        Abcam Products

        As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

        Read more +

        Investor Information

        Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

        Read more +

        Abcam News

        We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

        Read more +